Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Biopsy × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 17 Prostatic Neoplasms 11 Neoplasms 9 Lung Neoplasms 9 Uterine Cervical Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Stomach Neoplasms 4 Head and Neck Neoplasms 4 Skin Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Melanoma 3 Glioma 3 Glioblastoma 3 Colorectal Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Squamous Cell 3 Barrett Esophagus 3 Uterine Cervical Dysplasia 2 Thyroid Neoplasms 2 Sarcoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Medulloblastoma 2 Hematologic Neoplasms 2 Gliosarcoma 2 Glioma, Subependymal 2

Interventions

Radiotherapy 10 fludarabine phosphate 6 Cyclophosphamide 6 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 Cyclosporine 5 Whole-Body Irradiation 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Mycophenolic Acid 4 Melphalan 4 Drug Therapy 4 Cisplatin 4 Busulfan 4 Antilymphocyte Serum 4 Surveys and Questionnaires 3 Radiosurgery 3 Methotrexate 3 Injections 3 Cord Blood Stem Cell Transplantation 3 fludarabine 2 Vinblastine 2 Videotape Recording 2 Standard of Care 2 Procarbazine 2 Prednisolone 2 Practice Guidelines as Topic 2 Mastectomy 2 Lidocaine 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02613962 2020-02-17

MAPPYACTS

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡